# Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

> **NCT01151176** · PHASE4 · SUSPENDED · sponsor: **Universidade Positivo** · enrollment: 130 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Regular Insulin
- **DRUG:** Regular Insulin

## Key facts

- **NCT ID:** NCT01151176
- **Lead sponsor:** Universidade Positivo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2012-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-12
- **Target enrollment:** 130 (ESTIMATED)
- **Why stopped:** Administrative problems makes changes in hospital staff New clinical research team will restart
- **Last updated:** 2012-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01151176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01151176, "Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01151176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*